RPAM
MEDP icon

Rhenman & Partners Asset Management’s Medpace MEDP Stock Holding History

Rhenman & Partners Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.5M Buy
+8,500
New +$3.92M 0.42% 76
2025
Q2 		– Sell
-3,800
Closed -$1.16M – 102
2025
Q1 		$1.16M Sell
3,800
-3,000
-44% -$1.01M 0.13% 86
2024
Q4 		$2.26M Sell
6,800
-700
-9% -$237K 0.23% 78
2024
Q3 		$2.5M Buy
7,500
+5,000
+200% +$1.9M 0.2% 85
2024
Q2 		$1.03M Buy
+2,500
New +$990K 0.1% 89

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Rhenman & Partners Asset Management's MEDP Position: Q2 2026 in Review

Rhenman & Partners Asset Management opened a new position in Medpace (MEDP) in Q2 2026: 8,500 shares worth $4.5M. The stake represents 0.42% of the portfolio and ranks #76 among its holdings. This is a return to the name: Rhenman & Partners Asset Management previously reported a position in MEDP as recently as Q1 2025.

Rhenman & Partners Asset Management first reported a position in MEDP in Q2 2024 and has held it in 5 quarters since. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Rhenman & Partners Asset Management held 8,500 shares of Medpace worth $4.5M as of Q2 2026.
  • Medpace was a new Rhenman & Partners Asset Management position in Q2 2026.
  • Medpace made up 0.42% of Rhenman & Partners Asset Management's portfolio in Q2 2026, its #76 holding.
  • Rhenman & Partners Asset Management first reported a position in Medpace in Q2 2024 and has held it in 5 quarters since.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.